Literature DB >> 7893887

Management of injuries caused by Cryptococcus neoformans--contaminated needles.

A Casadevall1, J Mukherjee, R Yuan, J Perfect.   

Abstract

This report describes four skin-puncture accidents with needles that were heavily contaminated with Cryptococcus neoformans. In one accident, delayed administration of antifungal drugs resulted in a granuloma of the finger. In the other three accidents, no skin infection followed immediate prophylaxis with oral fluconazole. Our experience suggests that early therapy with fluconazole is a reasonable means of managing skin injuries caused by instruments contaminated with viable C. neoformans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7893887     DOI: 10.1093/clinids/19.5.951

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

1.  Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection.

Authors:  Kirsten Nielsen; Gary M Cox; Anastasia P Litvintseva; Eleftherios Mylonakis; Stephanie D Malliaris; Daniel K Benjamin; Steven S Giles; Thomas G Mitchell; Arturo Casadevall; John R Perfect; Joseph Heitman
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 2.  Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

Authors:  T G Mitchell; J R Perfect
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

3.  Applying genetics and molecular biology to the study of the human pathogen Cryptococcus neoformans.

Authors:  Cheryl D Chun; Hiten D Madhani
Journal:  Methods Enzymol       Date:  2010-03-01       Impact factor: 1.600

4.  Cryptococcus neoformans Virulence Assay Using a Galleria mellonella Larvae Model System.

Authors:  Piotr R Stempinski; Daniel F Q Smith; Arturo Casadevall
Journal:  Bio Protoc       Date:  2022-08-05

5.  Effect of virulence factors on the photodynamic inactivation of Cryptococcus neoformans.

Authors:  Renato A Prates; Beth Burgwyn Fuchs; Kazue Mizuno; Qurat Naqvi; Ilka T Kato; Martha S Ribeiro; Eleftherios Mylonakis; George P Tegos; Michael R Hamblin
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.